InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-23.3%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Cullen Michael T., Director. Officer active across 1 company, notably Panbela Therapeutics, Inc.. Cumulatively, 3 reports have been recorded. Breakdown: 1 buy · 0 sell. History available since 25 May 2021. The latest transaction was disclosed on 25 May 2021 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations3 total
165,000 sharesCommon StockSEC:0001437749-22-023776:0
Ideal exit: 1 Jul 2023 (T+270)
4,316 shares0Common StockSEC:0001437749-21-013591:0
4,316 shares0Common StockSEC:0001437749-21-013591
3 of 3 declarations
About Cullen Michael T.
Michael T. Cullen is a Board Member at Panbela Therapeutics, Inc. He plays a crucial role in the strategic direction of the company, which focuses on developing cancer treatments. His experience helps guide critical decisions for the company's future.
